Freenome, Inc.

US$10.18As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:FRNMHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR 0.50%
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) 0.60
PE TTM —
TSR TTM (4.86%)
Mkt cap US$1.094B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$12
22.51%
(7.17%)
Hold 12|6|5|10|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.21
0.20
0.19
0.19
5.41%
2.08%
2.02%
(3.23%)
Revenue$M
137.2
141.3
143.6
149.2
7.60%
8.72%
12.35%
12.82%
Peers (US$1.094B)
Cap (US$)
PE
1.712B
—
1.285B
—
Capital
TTM
5Y
10Y
Leveragex
1.776
0.114
0.119
EBIT/Intx
2.116
0.154
0.145
Own earn%
(90.37)
66.82
68.31
Sh yield%
44.39
30.71
34.95
Owners
Insiders/Inst%
9.10
78.15
Short interest%
1.25
SBC / revenue%
4.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
23–30
$1 testx
0.2
Incr. ROIC%
4